ACST - Acasti Pharma Tue 24'th Jan 2017
Stock analysis for Tue 24'th Jan 2017 (Updated daily)
Hold candidate since 2017-01-24
Acasti Pharma Stock Analysis
Acasti Pharma fell by -0.69% in the last day, from USD 1.45 to USD 1.44. The price has fallen in 5 of the last 10 days , but is still up by 16.13% over the past 2 weeks. Volume fell in the last day along with the stock, which is actually a good sign as volume should follow the stock. In the last day the trading volume fell by -1 205 181 shares and in total, 409 930 shares bought and sold for approx. USD 590 299.
Acasti Pharma lies in the middle of a very wide and weak falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -3.5% during the next 3 months and, with 90% probability hold a price between USD 1.06 and USD 1.70 at the end of this period.
Acasti Pharma holds buy signals from both short- and long-term moving averages. In addition, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down there will be some support from the lines at USD 1.31 and USD 1.29. A break down below any of these levels will issue sell signals. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sales signal was issued from a pivot top point on Monday January 23, 2017, which indicates further falls until a new bottom pivot has been found. Volume fell along with the price during the last trading day, which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk.
Relative Strength Index (RSI)
RSI14 is 61 and the stock is currently not being overbought or oversold
Support & Resistance
Acasti Pharma finds support from accumulated volume at USD 1.40, USD 1.38, and USD 1.33. On the upside the stock meets some resistance just above today's level from accumulated volume at USD 1.45 and USD 1.48.
The stock is about to test the resistance from accumulated volume at USD 1.45 and this may cause the stock to take a minor break or get into a more sideways move for a few days.
This stock may move much during a day (volatility) and with periodic low trading volume this stockstock is considered to be "high risk". During the last day, the stock moved USD 0.19 between high and low, or 13.48%. For the last week the stock has had a daily average volatility of 15.04%.
Our recommended stoploss: USD 1.36 (-5.56%) ( based on support and risk)
Acasti Pharma holds several positive signals, but we still don't find these to be enough for a buy-recommendation. At the current level we recommend a hold or accumulate position awaiting further development. Due to some small weaknesses in the technical picture we have downgraded our recommendation for this stock since last evaluation from a Strong Buy Candidate to a Hold/Accumulate.